Insulin therapy in GDM-I enhances glucose uptake, which in turn amplifies PKM2 expression and mTOR activation, likely through the direct stimulation of the insulin-Akt-mTOR axis [32]. The gene discussed is PKM; the disease is gestational diabetes.